BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 3528597)

  • 1. [Mechanism of the acute antihypertensive effect of captopril in patients on hemodialysis].
    Ishimitsu T; Yamakado M; Tagawa H
    Nihon Jinzo Gakkai Shi; 1986 Apr; 28(4):447-54. PubMed ID: 3528597
    [No Abstract]   [Full Text] [Related]  

  • 2. Participation of the renin-angiotensin system in the captopril-induced worsening of anemia in chronic hemodialysis patients.
    Hirakata H; Onoyama K; Hori K; Fujishima M
    Clin Nephrol; 1986 Jul; 26(1):27-32. PubMed ID: 3524928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of renin-angiotensin system does not cause skeletal muscle cramps during hemodialysis.
    Piergies AA; Atkinson AJ; Hubler GL; del Greco F
    Int J Clin Pharmacol Ther Toxicol; 1990 Oct; 28(10):405-9. PubMed ID: 2258248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the immediate hemodynamic effects of SQ 14225 (Captopril) and [Sar1, Ileu8] angiotensin II in patients with dialysis resistant hypertension.
    Iseki K; Onoyama K; Fujimi S; Fukiyama K; Omae T
    Clin Nephrol; 1982 Mar; 17(3):149-54. PubMed ID: 7039897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study concerning the maintenance of blood pressure during hemodialysis--the effect of humoral factors and cardiac performance].
    Imamura Y; Kubo H; Matsubara W; Kumagai H; Harada A; Matsumoto I; Takenaka M; Shiraishi T
    Nihon Jinzo Gakkai Shi; 1986 Apr; 28(4):439-45. PubMed ID: 3528596
    [No Abstract]   [Full Text] [Related]  

  • 7. [The treatment of severe arterial hypertension in patients with chronic kidney failure with captopril and beta-adrenoblockaders].
    Ermolenko VM; Lifshits NL; Zisel'man SB; Tatsievskiĭ VA
    Urol Nefrol (Mosk); 1991; (3):41-8. PubMed ID: 1871923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of captopril on blood pressure and renin-angiotensin-aldosterone system in hypertensive subjects after inhibition of renal vasodilative system.
    Santucci A; Aguglia F; De Mattia G; Cammarella I; Giordano M; Gnecchi M; Trinchieri F; Ficara C
    Int J Clin Pharmacol Res; 1984; 4(1):41-5. PubMed ID: 6381343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renin-angiotensin system in aminoglycoside-induced acute renal failure.
    Luft FC; Aronoff GR; Evan AP; Connors BA; Weinberger MH; Kleit SA
    J Pharmacol Exp Ther; 1982 Feb; 220(2):433-9. PubMed ID: 6276536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of an oral angiotensin I-converting enzyme inhibitor on blood pressure and renin-angiotensin-aldosterone system before and after nephrectomy in two cases with acute renovascular hypertension].
    Irabu N; Nakamura K; Morohashi Y; Murakami S; Kawamura K
    Nihon Jinzo Gakkai Shi; 1982 Sep; 24(9):1029-39. PubMed ID: 6298493
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship between vasopressin and the renin-angiotensin-aldosterone system in essential hypertension: effect of converting enzyme inhibitor on plasma vasopressin.
    Santucci A; Leonetti Luparini R; Ferri C; Ficara C; Giarrizzo C; Balsano F
    J Hypertens Suppl; 1985 Nov; 3(2):S133-4. PubMed ID: 3003302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of angiotensin I converting enzyme inhibitor (captopril) on blood pressure and bradykinin in patients with excessive aldosterone secretion].
    Haruyama K; Mizuno K; Yamazaki M; Toki T; Yaginuma K; Fukuchi S
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):437-44. PubMed ID: 6381834
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood concentration and urinary excretion of captopril (SQ 14,255), angiotensin converting enzyme activity and R-A-A system after administration of captopril--in patients with chronic renal failure compared with essential hypertension].
    Miyazaki N; Shionoiri H; Uneda S; Yasuda G; Gotoh E; Fujishima S; Kaneko Y; Kawahara Y; Yamazaki Y
    Nihon Jinzo Gakkai Shi; 1982 Apr; 24(4):421-8. PubMed ID: 6750186
    [No Abstract]   [Full Text] [Related]  

  • 15. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute changes in the renin-angiotensin-aldosterone system, catecholamines and prostaglandins during captopril in man.
    Lijnen P; Verschueren LJ; Fagard R; Staessen J; Amery A
    Methods Find Exp Clin Pharmacol; 1980 Dec; 2(6):293-301. PubMed ID: 6152995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal response to pentobarbital anesthesia in rats: effect of interrupting the renin-angiotensin system.
    Walker LA; Gellai M; Valtin H
    J Pharmacol Exp Ther; 1986 Mar; 236(3):721-8. PubMed ID: 3512818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibition with quinapril (CI-906) and captopril in spontaneously hypertensive rats with suppressed renin-angiotensin system.
    Säynävälammi P; Pörsti I
    Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):325-31. PubMed ID: 3309510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting effects of the renin-angiotensin system on renal function disclosed during converting enzyme inhibition in patients with renal hypertension.
    Rasmussen S; Ibsen H; Giese J
    Scand J Urol Nephrol Suppl; 1984; 79():49-52. PubMed ID: 6089319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of angiotensin II antagonist to blood pressure, plasma renin activity and plasma aldosterone concentration in chronic renal failure (author's transl)].
    Nigawara K; Yagihashi Y; Kogawa T; Kawamata A; Yamaya K; Sugawara S; Tulachan Y; Funyu T; Eba H; Kido K; Tanaka T; Morita S; Fukushi M; Furusawa M; Terayama Y; Hirayama N
    Nihon Jinzo Gakkai Shi; 1979 Nov; 21(11):1231-42. PubMed ID: 396404
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.